The use of vasopressin receptor antagonists in hyponatremia

被引:10
作者
Elhassan, Elwaleed A. [1 ]
Schrier, Robert W. [1 ]
机构
[1] Univ Colorado Denver, Div Renal Dis & Hypertens, Aurora, CO 80045 USA
关键词
aquaretics; hyponatremia; vaptans; vasopressin receptor antagonists; INAPPROPRIATE SECRETION; ANTIDIURETIC-HORMONE; SERUM SODIUM; DEMECLOCYCLINE TREATMENT; MILD HYPONATREMIA; WATER-RETENTION; HEART-FAILURE; CONIVAPTAN; FRACTURE; ASCITES;
D O I
10.1517/13543784.2011.553186
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Areas covered: This review presents a diagnostic approach for hyponatremia and discusses some therapeutic considerations. It displays new evidence linking mild chronic hyponatremia with unfavorable outcomes and examines the available treatment options and their limitations and strengths. New data on vaptans and their potential role to treat hyponatremia in different clinical settings are reviewed. Expert opinion: Vaptans are likely to play an important role in treating hyponatremia, given their clinical efficacy and tolerability. High cost remains an impediment for vaptans, and more studies are needed to further define their best use in hyponatremic patients.
引用
收藏
页码:373 / 380
页数:8
相关论文
共 50 条
[1]   Rationale and Design of the Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation (THE BALANCE) Study [J].
Abraham, William T. ;
Aranda, Juan M. ;
Boehmer, John P. ;
Elkayam, Uri ;
Gilbert, Edward M. ;
Gottlieb, Stephen S. ;
Hasenfuss, Gerd ;
Kukin, Marrick ;
Lowes, Brian D. ;
O'Connell, John B. ;
Tavazzi, Luigi ;
Feldman, Arthur M. ;
Ticho, Barry ;
Orlandi, Cesare .
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2010, 3 (05) :249-253
[2]   Incidence, causes and prognostic factors of hyponatremia in an intensive care unit [J].
Bennani, SL ;
Abouqal, R ;
Zeggwagh, AA ;
Madani, N ;
Abidi, K ;
Zekraoui, A ;
Kerkeb, O .
REVUE DE MEDECINE INTERNE, 2003, 24 (04) :224-229
[3]   A Patient With Severe Hyponatremia and Hypokalemia: Osmotic Demyelination Following Potassium Repletion [J].
Berl, Tomas ;
Rastegar, Asghar .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (04) :742-748
[4]   Oral Tolvaptan Is Safe and Effective in Chronic Hyponatremia [J].
Berl, Tomas ;
Quittnat-Pelletier, Friederike ;
Verbalis, Joseph G. ;
Schrier, Robert W. ;
Bichet, Daniel G. ;
Ouyang, John ;
Czerwiec, Frank S. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (04) :705-712
[5]   DEMECLOCYCLINE TREATMENT IN SYNDROME OF INAPPROPRIATE ANTIDIURETIC-HORMONE SECRETION [J].
CHERRILL, DA ;
STOTE, RM ;
BIRGE, JR ;
SINGER, I .
ANNALS OF INTERNAL MEDICINE, 1975, 83 (05) :654-656
[6]   DEMECLOCYCLINE TREATMENT OF WATER-RETENTION IN CONGESTIVE HEART-FAILURE [J].
DEBEYL, DZ ;
NAEIJE, R ;
DETROYER, A .
BMJ-BRITISH MEDICAL JOURNAL, 1978, 1 (6115) :760-760
[7]   INAPPROPRIATE SECRETION OF ANTI-DIURETIC HORMONE TREATED WITH FRUSEMIDE [J].
DECAUX, G ;
WATERLOT, Y ;
GENETTE, F ;
HALLEMANS, R ;
DEMANET, JC .
BRITISH MEDICAL JOURNAL, 1982, 285 (6335) :89-90
[8]   USE OF UREA FOR TREATMENT OF WATER-RETENTION IN HYPONATRAEMIC CIRRHOSIS WITH ASCITES RESISTANT TO DIURETICS [J].
DECAUX, G ;
MOLS, P ;
CAUCHI, P ;
DELWICHE, F .
BRITISH MEDICAL JOURNAL, 1985, 290 (6484) :1782-1783
[9]   Treatment of euvolemic hyponatremia in the intensive care unit by urea [J].
Decaux, Guy ;
Andres, Caroline ;
Kengne, Fabrice Gankam ;
Soupart, Alain .
CRITICAL CARE, 2010, 14 (05)
[10]   EFFECTS OF DEMETHYLCHLORTETRACYCLINE ON CELLULAR ACTION OF ANTIDIURETIC-HORMONE INVITRO [J].
DOUSA, TP ;
WILSON, DM .
KIDNEY INTERNATIONAL, 1974, 5 (04) :279-284